Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap56.99B
Enterprise Value58.76B
P/E Ratio-52.33
PEG Ratio3.25
Price/Sales Ratio19.71
Price/Book Ratio15.72
Enterprise/Revenue22
Enterprise/EBITDA-101.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.38
Operating Margin-0.34
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.29

Income Statement

Revenue875.13M
Revenue/Share1.01
Gross Profit132.41M
EBITDA-188.91M
Net Income-357.9M
Diluted EPS-0.39

Balance Sheet

Total Cash72.08M
Total Cash/Share0.08
Total Debt2.21B
Total Debt/Equity1.89
Current Ratio0.67
Book Value Per Share1.22

Price History

52-Week Change-61.4
52-Week High70
52-Week Low18.36
Moving Average 50 Days21.59
Moving Average 200 Days32.39

Statistics

Average Volume22.44M
Shares Outstanding919.06M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.33
Last Split Factor9:5
Last Split DateApril 20, 2016
AD